stockrowenVVeno Medical Corporation
NVNO Healthcare Medical Devices
- EPS
- +22.0%
- Free cash flow
- +27.6%
Quarter to September 2026, against a year earlier
Follow NVNO
Alert me
enVVeno Medical Corporation (NVNO) EV/Sales
As of 6 November 2026, enVVeno Medical Corporation (NVNO) trades at a EV/Sales of −50.8×. Over the past ten years it has ranged from −108× (December 2025) to 408× (July 2025); the current reading is higher than 12% of that period. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2019 | 63.7× | (23.82%) |
| FY2018 | 83.7× | (33.28%) |
| FY2017 | 125× | 0.00% |
| FY2016 | 125× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Mar 2019 | 120× | 43.20% |
| Dec 2018 | 83.7× | (15.24%) |
| Sep 2018 | 98.7× | 22.65% |
| Jun 2018 | 80.5× | (35.83%) |
| 5 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NVNO enVVeno Medical Corporation | −50.8× |
| TNON Tenon Medical, Inc. compare | −0.2× |
| WOK WORK Medical Technology Group LTD compare | n/m |
| BDMD Baird Medical Investment Holdings Limited compare | n/m |
| TBIO Telesis Bio Inc. compare | 0.1× |
| INBS Intelligent Bio Solutions Inc. compare | 0.3× |
| XAIR Beyond Air, Inc. compare | 1.1× |
| TRIB Trinity Biotech PLC compare | 3.0× |
| VNRX VolitionRX Limited compare | 4.1× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)